E. Puca

发表

D. Toni, S. Lorenzano, M. Prencipe, 2006, Neurological Sciences.

A Randomized Controlled Trial Effects of Sapropterin on Endothelium-Dependent Vasodilation in Patients With

L. Pantoni, D. Inzitari, A. Federico, 2014 .

Immunocytokines are a promising immunotherapeutic approach against glioblastoma

M. Weller, P. Roth, D. Neri, 2020, Science Translational Medicine.

Immunotherapy with Immunocytokines and PD-1 Blockade Enhances the Anticancer Activity of Small Molecule-Drug Conjugates Targeting Carbonic Anhydrase IX

A. Villa, D. Neri, S. Cazzamalli, 2020, Molecular Cancer Therapeutics.

Comparative evaluation of bolus and fractionated administration modalities for two antibody-cytokine fusions in immunocompetent tumor-bearing mice.

F. Seehusen, D. Neri, R. De Luca, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Comparative evaluation of bolus and fractionated administration modalities for two antibody-cytokine fusions in immunocompetent tumor-bearing mice

F. Seehusen, D. Neri, R. De Luca, 2019 .

Generation and in vivo validation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibody

G. Tortora, C. Halin, M. Matasci, 2022, Journal for ImmunoTherapy of Cancer.

Efficacy of acute ischemic stroke patients management in an emergency department stroke unit (EDSU).

E. Angelantonio, C. Colosimo, D. Toni, 2005 .

Selection of a PD‐1 blocking antibody from a novel fully human phage display library

F. Forneris, A. Villa, D. Neri, 2022, Protein science : a publication of the Protein Society.

The antibody‐based delivery of interleukin‐12 to solid tumors boosts NK and CD8+ T cell activity and synergizes with immune checkpoint inhibitors

A. Villa, S. Wulhfard, M. Matasci, 2020, International journal of cancer.

The antibody-based delivery of interleukin-12 to solid tumors boosts NK and CD8+ T cell activity and synergizes with immune check-point inhibitors

A. Villa, S. Wulhfard, M. Matasci, 2019, bioRxiv.

Effects of Sapropterin on Endothelium-Dependent Vasodilation in Patients With CADASIL: A Randomized Controlled Trial

L. Pantoni, D. Inzitari, A. Federico, 2014, Stroke.

Stroke Prediction after Transient Ischemic Attacks in Patients Admitted to a Stroke Unit

P. Stanzione, V. Di Lazzaro, F. Orzi, 2011, European Neurology.

Impaired vasoreactivity in mildly disabled CADASIL patients

L. Pantoni, D. Inzitari, A. Federico, 2011, Journal of Neurology, Neurosurgery & Psychiatry.

Feasibility and clinical utility of transesophageal echocardiography in the acute phase of cerebral ischemia.

S. De Castro, E. Di Angelantonio, D. Toni, 2010, The American journal of cardiology.

An emergency clinical pathway for stroke patients – results of a cluster randomised trial (isrctn41456865)

M. Ferri, D. Toni, P. Giorgi Rossi, 2009, BMC health services research.

Generation and in vivo characterization of a novel high-affinity human antibody targeting carcinoembryonic antigen

A. Oxenius, Abdullah Elsayed, Sheila Dakhel Plaza, 2023, mAbs.

A Case of Anti-Leucine-Rich Glioma-Inactivated Protein 1 (Anti-LGI1) Encephalitis With an Unusual Frontomesial Motor Cortex T2 MRI Hyperintensity

C. Cagnetti, C. Paci, E. Puca, 2022, Cureus.

Targeted delivery of tumor necrosis factor in combination with CCNU induces a T cell–dependent regression of glioblastoma

I. Amit, B. Becher, A. Weiner, 2023, Science Translational Medicine.

285MO The combination of lomustine and antibody-based targeted TNF (L19TNF) as a promising treatment for recurrent glioblastoma

P. Roth, T. Weiss, T. Look, 2022, Annals of Oncology.

Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation properties

C. Halin, M. Manz, J. Mock, 2023, mAbs.

An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties

E. Gilardoni, F. Seehusen, T. Weiss, 2023, Pharmaceutics.

Clinical Features of Patients With Cervical Artery Dissection and Fibromuscular Dysplasia.

R. Calabró, A. Adami, V. Caso, 2021, Stroke.

The targeted delivery of interleukin-12 to the carcinoembryonic antigen increases the intratumoral density of NK and CD8+ T cell in an immunocompetent mouse model of colorectal cancer.

D. Neri, Davorin Bajić, E. Puca, 2020, Journal of gastrointestinal oncology.

Intravenous thrombolysis in CADASIL: report of two cases and a systematic review

L. Pantoni, A. Poggesi, F. Pescini, 2022, Neurological Sciences.

An Antibody Targeting Fibroblast Activation Protein Simultaneously Fused to Interleukin-2 and Tumor Necrosis Factor Selectively Localizes to Neoplastic Lesions

E. Gilardoni, R. De Luca, E. Puca, 2023, Antibodies.

Effects of Sapropterin on Endothelium-Dependent Vasodilation in Patients With CADASIL: A Randomized Controlled Trial

L. Pantoni, D. Inzitari, A. Federico, 2014, Stroke.

Impaired vasoreactivity in mildly disabled CADASIL patients

L. Pantoni, D. Inzitari, A. Federico, 2011, Journal of Neurology, Neurosurgery & Psychiatry.

A novel strategy to generate immunocytokines with activity-on-demand using small molecule inhibitors

E. Gilardoni, Abdullah Elsayed, Sheila Dakhel Plaza, 2024, EMBO molecular medicine.